Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XPF-002 in Postherpetic Neuralgia
NCT01195636Phase 2Completed
- Sponsor
- Xenon Pharmaceuticals
- Start
- Aug 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of funapide in postherpetic neuralgia (PHN), sponsored by Xenon Pharmaceuticals. Started Aug 2010; status: completed.
02
Drugs
funapide
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01195636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01195636.